Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLC601 in Mild to Moderate Alzheimer's Disease
NCT01696123Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of mlc601 in Alzheimer's disease (AD), sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2011; status: completed.
02
Drugs
mlc601
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01696123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696123.